4DMedical Ltd. 4DX

Australia’s cash rate is now at a 15 year high of 4.6%, which puts real pressure on slower growing businesses. Faster earnings growth can matter more when money is this expensive, because the market often rewards companies that can still expand profits while others struggle. This article highlights three Australian stocks from a high growth opportunity screen that analysts expect to deliver solid earnings momentum and maintain broadly healthy balance sheets. The three stocks below are only a...

Rising global bond yields are lifting borrowing costs and pressuring richly priced growth stories. Yet Australian companies with solid balance sheets and credible earnings expansion forecasts still attract attention. That mix of resilience and growth potential can be hard to find, which creates a real fear of missing out when it appears. This article highlights three stocks from a high quality Australian growth screener that fit that profile. The three stocks below are just a starting sample...